In contrast, we have shown that CD4 T-cell responses to an immunodominant AFP-derived peptide are only detectable in HCC patients, and this response is mainly detected in patients with low serum AFP concentrations and early-stage disease (Alisa et al, 2005). The gene discussed is AFP; the disease is hepatocellular carcinoma.